|
757 Pharmacy potential
not being realised, says APPG Pharmacists'
potential as health care providers is not being realised quickly or consistently
enough, the All-Party Pharmacy Group has concluded
PJ 2007;278:757
Full Text
757 Pharmacy contract fails to stimulate
innovation The community pharmacy contract
in England and Wales has widened the use of existing services rather
than stimulated innovative practice, a summary of research funded by
the Pharmacy Practice Research Trust suggests
PJ 2007;278:757
Full Text
757 Pharmacy stays open despite severe flooding Sheffield
pharmacy Associated Chemists (Wicker) Ltd has maintained its record of opening
every day since 1952 despite being under water earlier this week. Customers came
and went by boat
PJ 2007;278:757
Full Text
757 SoP report takes global look at smoking
cessation Pharmacists' role in helping people give
up smoking is highlighted in a University of London School of Pharmacy report,
published this week
PJ 2007;278:757
Full Text
758 Early implementer sites
for release 2 of EPS named Early implementer sites
for release 2 of the electronic prescription service have been announced by the
Department of Health and NHS Connecting for Health
PJ 2007;278:758
Full Text
758 Non-pharmacist appointed to lead the NPA Alison
White, interim chief executive of Business Link London, has been appointed chief
executive of the National Pharmacy Association. She will start on 2 July 2007
PJ 2007;278:758
Full Text
758 CPPE to be scrutinised in independent evaluation The
Centre for Pharmacy Postgraduate Education is to be evaluated by the University
of Birmingham's school of education to ensure that it is continuing to meet the
needs of the NHS and the pharmacy workforce
PJ 2007;278:758
Full Text
758“Iron bar pharmacist” remanded in custody Suspended
pharmacist Samuel Edwin Ashby, who attacked a member of the Royal Pharmaceutical
Society's staff at a Statutory Committee hearing on 25 October last year, has
been jailed
PJ 2007;278:758
Full Text
758 Remuneration reduction not as much as first
announced Monthly NHS remuneration for community
pharmacies in England and Wales will not be reduced by as much as was announced
earlier this month
PJ 2007;278:758
Full Text
758 Incentive scheme guidance Advice
on the principles that primary care trusts should adopt in framing and administering
incentive schemes has been issued by the Department of Health
PJ 2007;278:758
Full Text
758 Generics case settled Goldshield,
one of a number of suppliers of generic medicines being sued for damages by the
Department of Health after being accused of illegal price-fixing, has settled
with the DoH
PJ 2007;278:758
Full Text
759 Chlamydia treatment could
soon be available OTC People with asymptomatic
chlamydia infection could soon buy treatment for the condition over the counter
at community pharmacies
PJ 2007;278:759
Full Text
759 New option for patients with hepatitis B A
thymidine nucleoside analogue antiviral drug for treating hepatitis B has been
launched this week by Novartis
PJ 2007;278:759
Full Text
759 Scotland and Wales add their support for
HPV vaccine Ministers in Scotland and Wales have
echoed Department of Health support for providing a human papillomavirus vaccine
as part of the childhood vaccination programme
PJ 2007;278:759
Full Text
759 Sorafenib rejected in Wales Use
of sorafenib (Nexavar; Bayer) in NHS Wales has been rejected by the All Wales
Medicines Strategy Group
PJ 2007;278:759
Full Text
759 NICE advises on treatments for glioma and
alteplase for acute ischaemic stroke Temozolomide
has been endorsed by the National Institute for Health and Clinical Excellence
as a treatment option for newly diagnosed high-grade glioma
PJ 2007;278:759
Full Text
760 Risk of confusion over
cytarabine Confusion between cytarabine and liposomal
cytarabine has been highlighted as a potential risk in an early warning report
issued by the National Patient Safety Agency
PJ 2007;278:760
Full Text
760 New restrictions on piroxicam prescribing New
restrictions on the use of piroxicam have been issued by the European Medicines
Agency (EMEA) because of the risk of gastrointestinal side effects and serious
skin reactions. The restrictions apply to the oral, injectable and suppository
forms of the drug but not to topical preparations
PJ 2007;278:760
Full Text
760 Contamination may lead to suspension of
Viracept Roche's anti-HIV medicine Viracept (nelfinavir
mesilate) has been recommended for suspension by the European Medicines Agency
PJ 2007;278:760
Full Text
760 Presentation of risk influences consent The
way in which a treatment's effect is described, even when descriptions are quantitatively
equal, influences patients' willingness to take that treatment, according to
research published last week
PJ 2007;278:760
Full Text
761 Primary care pharmacist
job losses to be quantified Primary care pharmacists
will find out later this summer how many of their jobs have disappeared because
of recent budget cuts and NHS reorganisation
PJ 2007;278:761
Full Text
761 NPA highlights potential for waste medicine
problem if new disposal directive goes ahead Pharmacies
might have to stop accepting medicines for disposal from the public, according
to a warning issued this week by the National Pharmacy Association in Scotland
PJ 2007;278:761
Full Text
761 Alliance Boots leaves European wholesalers'
association Alliance Boots has withdrawn from the European Association of Pharmaceutical Full-line Wholesalers (GIRP) because of differences of “outlook and approach” relating to direct-to-pharmacy distribution arrangements in the UK
PJ 2007;278:761
Full Text
761 Boots in private hands Alliance
Boots became privately owned on 26 June
PJ 2007;278:761
Full Text
761 Stock trading system launched An
internet-based stock trading system, endorsed by the National Pharmacy Association,
is being rolled out across the UK from 1 July
PJ 2007;278:761
Full Text
761 Echinacea in common cold Echinacea
can reduce both the incidence and duration of the common cold, a meta-analysis
of 14 studies indicates
PJ 2007;278:761
Full Text
762 Response to methylamphetamine
threat needs balance, MHRA told Controls over pseudoephedrine
and ephedrine need to be balanced and proportionate, the Serious Organised Crime
Agency has told the Medicines and Healthcare products Regulatory Agency
PJ 2007;278:762
Full Text
762 P medicines should not be self-selected Pharmacy-only
medicines must not be available for self-selection by members of the public,
the Royal Pharmaceutical Society's Council has concluded following its consultation
on the matter, which closed in April this year
PJ 2007;278:762
Full Text
762 PAGB believes pseudoephedrine reclassification
will negatively impact on self care On the limited
evidence available, it seems wrong for millions of people to lose access to medicines
containing pseudoephedrine, outgoing president of the Proprietary Association
of Great Britain, John Harold, said at the association's annual dinner last week
PJ 2007;278:762
Full Text
762 NPA draws up training ahead of pseudoephedrine
decision A training programme to raise awareness
of issues around the potential misuse of pseudoephedrine- and ephedrine-containing
products is being prepared by the National Pharmacy Association
PJ 2007;278:762
Full Text
762 PRODUCT RECALL Prosulf Prosulf
(protamine sulphate; CP) injection 10mg/ml batch 07 is being recalled, because
the finished product has failed to meet normal assay criteria
PJ 2007;278:762
Full Text |
The
Pharmaceutical Journal